Navigation Links
The Debiopharm Life Sciences Award Goes to Dr Lluis Quintana-Murci for his Novel and Original Research on the Human Evolutionary Genetics of Infection
Date:9/3/2009

LAUSANNE, Switzerland, September 3 /PRNewswire/ -- Debiopharm Group, SA (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today presented the 'Debiopharm Life Sciences Award' to Dr Lluis Quintana-Murci from the Institut Pasteur in France, for his outstanding innovative research in the emerging field of evolutionary genetics of infection. Funded by Debiopharm, the ceremony took place at the EPFL (Ecole Polytechnique Federale de Lausanne) during the EPFL School of Life Sciences Inaugural Symposium. Dr Quintana-Murci and his institute received a total of CHF 100'000.

Dr Quintana-Murci leads the research unit of "Human Evolutionary Genetics" within the Department of Genomes and Genetics at the Pasteur Institute in Paris. His work focuses on understanding the mechanisms of host defence and infection in the natural setting, namely how pathogens have exerted selective pressures on human genes involved in immunity or host-pathogen interactions. In the past, scientists have used cellular and molecular biology, immunology or classical genetics to study the biology and immunology of infection. Dr Quintana-Murci has used a novel approach called "evolutionary genetics of infection" that has helped in the understanding of how pathogens have contributed to shape the human genome. A direct consequence of his work is the identification of a number of genes that are the key players of host defence against infection.

"We were impressed by the work of Dr Quintana-Murci and his colleagues," said Dr Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "He has taken the study of host-pathogen interactions to a higher level, where the pathogen is now recognised as a key driver of genetic selection. His novel and original approach of studying infection biology may have direct implications in the development
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Curis and Debiopharm Sign an Exclusive License Agreement Covering the HSP90 Inhibitor CUDC-305
2. Debiopharm and MSM Protein Technologies Sign Agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
3. Debiopharm Group and Moffitt Cancer Center Sign Development and Commercialisation Agreement for Small Molecule Debio 0928 in Early Preclinical Development for Treatment of Solid Tumours
4. Debiopharm and Pharmaleads Sign License Agreement for Debio 0827 or PL37 in Treatment of Chronic Pain Conditions
5. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
6. Japanese Cancer Association and Debiopharm Honour Japanese Research
7. Debiopharm Signs License Agreement for Marketing of Salvacyl(R)/Moapar(R) 3-Month in Treatment of Sexual Deviations
8. Debiopharm and EPFL Establish an Oncology Chair
9. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
10. Debiopharm Receives cGMP Certification for Quality Control of its Drug Products
11. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... DUBLIN , Sept. 29, 2014 ... "Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph ... Application, & Region - Global Trends & Forecast to ... A process analyzer is a process analytical ... in real-time. It has redefined the way by which ...
(Date:9/29/2014)... (PRWEB) September 29, 2014 Transparency Market ... Synthesis - SPPS, LPPS, HPPS, by Application - Cancer, ... & Generic and by Delivery) - Global Industry Analysis, ... states that the global peptide therapeutics market was worth ... US$25.4 billion by 2018 at an 8.7% CAGR. , ...
(Date:9/29/2014)... CAMBRIDGE, Mass. , Sept. 29, 2014  Atlas ... promising life sciences and technology innovation, today announced that ... of Epizyme (NASDAQ: EPZM ), is joining ... effective October 1, 2014. At Atlas, Rhodes ... build groundbreaking companies. He brings an accomplished record in ...
(Date:9/29/2014)... /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: SQD) (OTCQX: SQIDF), ... technologies and products for advanced microarray diagnostics, is pleased ... to Chairman of the Board of Directors of SQI, ... to serve as a Director on the Board and ... "We are very pleased to have Mr. ...
Breaking Biology Technology:Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 2Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 3Global Process Liquid Analyzer, Gas Analyzer, and Gas Chromatograph (PH/ORP, Chlorine, Oxygen, Carbon dioxide) Market - Trends & Forecast to 2020 4Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3Atlas Venture Names Jason Rhodes, Veteran Investor and President and CFO of Epizyme, As Partner on Life Sciences Investing Team 2SQI Diagnostics Announces New Chairman of Board of Directors 2
... ... Improves Bowel Function, CAMBRIDGE, England, September 26 The ... patients with chronic severe pain,compared to treatment with oxycodone alone, according ... Congress, Budapest(1). A Phase III trial of 463 patients was ...
... Next Generation Sequence Analysis Problem -, - Exhibit ... Tool -, MISSION VIEJO, Calif., Sept. 26 ... its innovative genomic search,technology, SLIM Search, Inc. announces ... Second International Next Generation,Sequencing Conference. The conference will ...
... as President and CSO, MONTREAL and SAN ... held biotechnology company developing,first-in-class Leukocyte Population Modulators (LPMs) ... Jack M. Anthony to Chief,Executive Officer. Dr. Philip ... continue as President and assume the new role ...
Cached Biology Technology:New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain 2New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain 3SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 2SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 3SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market 4Osprey Pharmaceuticals Names Jack M. Anthony as CEO 2Osprey Pharmaceuticals Names Jack M. Anthony as CEO 3
(Date:9/29/2014)... in Behavioral Brain Research provides novel insight ... result of chronic alcohol exposure that can lead to ... and research indicate that individuals with alcohol use disorders ... when people are actively drinking, when they are going ... "Sleep-wake disturbances can last for months, or even years, ...
(Date:9/29/2014)... deemed inaccessible or esoteric. Yet in the modern world, ... daily lives and a decisive role in the discovery ... scenes. , UC Santa Barbara,s Paul Atzberger, a professor ... of mechanical engineering, often works in areas where science ... in the Proceedings of the National Academy of ...
(Date:9/29/2014)... the supercontinent of Pangea was starting to break up and ... of reptiles called phytosaurs and rauisuchids were at the top ... two top predators didn,t interact much as the former was ... But those ideas are changing, thanks largely to the contents ... in September in the German journal Naturwissenschaften ...
Breaking Biology News(10 mins):At the interface of math and science 2At the interface of math and science 3At the interface of math and science 4Tooth buried in bone shows prehistoric predators tangled across land, sea 2
... physical world. That,s a fact cancer researchers are beginning to ... mathematics in their efforts to understand how cancer develops -- ... researchers at the University of Michigan Comprehensive Cancer Center, has ... of the top cancer research journals and a new grant ...
... once discussed only in scientific or eco-centric circles, has ... sustainability remains elusive. On Friday, scholars and legal ... address how to meet mankind,s present needs without compromising ... The Environmental & Energy Law & Policy Journal,s fifth ...
... chemicals from plant material could produce liquid fuel for just ... the infrastructure is set up in the right way, states ... Bioproducts & Biorefining . Developed by scientists at the ... as bioliq, and is able to produce a range of ...
Cached Biology News:Physics, math provide clues to unraveling cancer 2Symposium at UH will address how to put 'sustainability' into practice 2Novel technology could produce biofuel for around 0.50 a liter ($2.49 a gallon) 2
... Electrophoresis Running Buffer was designed to meet ... of todays sequencing labs. As a primary ... the gel-based sequencing community Sigma has the ... meet your buffer needs. Scientists at Sigma ...
... Excalibur™ mid-, near- and far-infrared range FT-IR ... performance in their class. Yet all this ... Features: Highest-energy throughput: Having a larger ... compared to other conventional FT-IRs provides 300%,larger ...
... 8800 Genetic Analysis System, which processes two 96-well ... system adds a higher level of throughput to ... part of Beckman Coulters new GenomeLab family of ... the Biomek series liquid handers, for increased automation. ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
Biology Products: